| Literature DB >> 25409033 |
Ping Lu1, Artur Mailyan, Zhenhua Gu, David M Guptill, Hengbin Wang, Huw M L Davies, Armen Zakarian.
Abstract
The evolution of a program directed at the enantioselective total synthesis of maoecrystal V, a highly modified ent-kauranoid, is described. An early stage chiral auxiliary-directed asymmetric C-H functionalization for the construction of a key benzofuran intermediate enabled the first asymmetric synthesis of the natural enantiomer of maoecrystal V, confirming the assigned stereochemistry. A divergent course of the central intramolecular Diels-Alder reaction, which is dependent on the nature of the dienophile, initially led to the development of an unanticipated and previously unknown isomer of maoecrystal V, which we named maoecrystal ZG. In light of the reported selective and potent cytotoxic activity of maoecrystal V, the cytotoxic properties of maoecrystal ZG were also investigated.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25409033 PMCID: PMC4291805 DOI: 10.1021/ja510573v
Source DB: PubMed Journal: J Am Chem Soc ISSN: 0002-7863 Impact factor: 15.419
Figure 1General structures and selected members of ent-kaurane diterpenoids from Isodon plants.
Scheme 1Abbreviated Presentation of the Total Synthesis of (−)-Maoecrystal V (1) and Maoecrystal ZG (2)
Scheme 2Synthesis Plan
Scheme 3Enantioselective C–H Insertion with Diazo Ester 9a
| entry | catalyst | solvent | yield (%) | ee, | ee, | |
|---|---|---|---|---|---|---|
| 1 | Rh2( | CH2Cl2 | 25 | 9.1:1 | 70 | 50 |
| 2 | Rh2( | EtOAc | trace | |||
| 3 | Rh2( | hexane | 34 | 6.7:1 | 51 | |
| 4 | Rh2( | PhMe | 47 | 5.9:1 | −60 | −33 |
| 5 | Rh2( | CH2Cl2 | 27 | 9.1:1 | 54 | |
| 6 | Rh2( | CH2Cl2 | 42 | 30 | 18 | |
| 7 | Rh2( | CH2Cl2 | trace | |||
| 8 | Rh2( | CH2Cl2 | 53 | 10.0:1 | 60 | |
| 9 | Rh2( | CH2Cl2 | 22 | 3.7:1 | 48 | |
| 10 | Rh2( | CH2Cl2 | NR | |||
| 11 | Rh2( | CH2Cl2 | trace | |||
| 12 | Rh2( | CH2Cl2 | trace | 1:1 | ||
| 13 | Rh2( | CH2Cl2 | 24 | 3:1 | 8 |
Diastereomer ratios and enantiomeric excess were determined by HPLC analysis.
Combined isolated yield of cis-10 and trans-10.
At reflux.
Figure 2Chiral rhodium catalysts used in asymmetric C–H functionalization of 9, 11, and 22.
Enantioselective C–H Insertion with Diazo Esters 11a
| entry | R | catalyst | solvent | yield % | ee, | ee, | |
|---|---|---|---|---|---|---|---|
| 1 | Me | Rh2( | DMB | 71 | 1.4:1 | 45 | 80 |
| 2 | Me | Rh2( | CHCl3 | 63 | 1.6:1 | 49 | 67 |
| 3 | Me | Rh2( | 69 | 1.6:1 | 41 | 77 | |
| 4 | Rh2( | DMB | 55 | 3.0:1 | <5 | 66 | |
| 5 | Rh2( | CHCl3 | 28 | 3.0:1 | <5 | 57 | |
| 6 | Rh2( | 70 | 3.5:1 | 23 | 59 | ||
| 7 | Me | Rh2( | 79 | 1.0:1 | 18 | 57 | |
| 8 | Me | Rh2( | 76 | 1:1.1 | ∼42 | ∼78 | |
| 9 | Me | Rh2( | 74 | 2.2:1 | 29 | 56 | |
| 10 | Me | Rh2( | 79 | 1.4:1 | 41 | 54 | |
| 11 | Me | Rh2( | 76 | 1:1.1 | ∼43 | ||
| 12 | Me | Rh2( | 78 | 1:1.4 | ∼10 | 38 | |
| 13 | Me | Rh2( | 65 | 3.8:1 | ∼36 | ∼11 | |
| 14 | Me | Rh2( | 74 | 1:1.1 | 19 | ∼18 | |
| 15 | Me | Rh2( | 71 | 1.0:1 | <5 | 7 | |
| 16 | Me | Rh2( | 73 | 1.9:1 | ∼19 | ∼45 | |
| 17 | Rh2( | 77 | 2.8:1 | 42 | 63 | ||
| 18 | Rh2( | 77 | 2.5:1 | ∼46 | 46 | ||
| 19 | Rh2( | 83 | 3.3:1 | 13 | 24 |
Diastereomer ratios determined by 1H NMR analysis of crude reaction mixture. Enantiomeric excesses were determined by HPLC analysis.
Combined isolated yield of cis-12 and trans-12.
Scheme 4
Scheme 5
Scheme 6Lactamide and Mandelamide as Chiral Auxiliaries
| entry | starting material | catalyst | solvent | yield 1
(%) | yield 2
(%) | ee % |
|---|---|---|---|---|---|---|
| 1 | Rh2( | CH2Cl2 | <10 | |||
| 2 | Rh2( | CH2Cl2 | <10 | |||
| 3 | Rh2( | CH2Cl2 | 63 | 83 | 62 | |
| 4 | Rh2( | CH2Cl2 | 74 | 86 | 70 | |
| 5 | Rh2(OAc)4 | CH2Cl2 | 84 | 84 | 65 | |
| 6 | Rh2(O2CC4F9)4 | CH2Cl2 | 0 | |||
| 7 | Rh2( | (CH2Cl)2 | 72 | |||
| 8 | Rh2( | PhMe | 61 | |||
| 9 | Rh2( | <10 | ||||
| 10 | Rh2( | CH3CN | 0 | |||
| 11 | Rh2( | CH2Cl2 | 84 | 89 | 59 | |
| 12 | Rh2( | CH2Cl2 | 57 | 77 | 52 | |
| 13 | Rh2(OAc)4 | CH2Cl2 | 72 | 85 | 76 | |
| 14 | Rh2(OAc)4 | CH2Cl2 | 61 | 84 | 84 |
Isolated yield.
Combined isolated yield.
Isolated yield, complete isomerization to the trans isomer observed.
Major diastereomer isolated in pure form by column chromatography.
Determined by HPLC.
Figure 3Potential products of the key IMDA reaction considered for the total synthesis of maoecrystal V.
Scheme 7
Scheme 8
Scheme 9
Scheme 10
Scheme 11
Scheme 12| entry | X | Y | reagent solvent | temp (°C), time (h) | a:b:c |
|---|---|---|---|---|---|
| 1 | H | H, OBn | Bu4NF, DMSO | 0, 0.2 | 1.0:1.8:1 (20%) |
| 2 | H | H, OBn | Bu4NF, DMSO | 23, 0.2 | 0.9:1.5:1 |
| 3 | H | H, OBn | Bu4NF, DMF | –20, 2 | 1.5:1.3:1 |
| 4 | H | H, OBn | Bu4NF, DMF | 0, 0.5 | 2.3:1.8:1 |
| 5 | H | H, OBn | Bu4NF, DMF | 23, 0.3 | 1.9:1.6:1 |
| 6 | H | H, OBn | Bu4NF, DMF, (slow addition) | 23, 3.2 | 1.6:1.3:1 |
| 7 | H | H, OBn | Bu4NF, NMP | 0, 1.0 | 1.4:1.7:1 |
| 8 | H | H, OBn | Bu4NF, DMPU | 0, 1.0 | 3.2:1.8:1 |
| 9 | H | H, OBn | Bu4NF, DMA | 0, 0.5 | 2.4:1.7:1 |
| 10 | H | H, OBn | Bu4NF, DMSO– | 75, 1 | 0.3:1.2:1 |
| 11 | H | H, OBn | Bu4NF, AcOH, THF | 0, 1.0 | no reaction |
| 12 | H | H, OBn | CsF, | 70, 15 | no reaction |
| 13 | H | H, OBn | Bu4NPh3SiF2, DMSO | 50, 36 | 0:20:1 |
| 14 | H | H, OBn | Bu4NPh3SiF2, | 50, 15 | no reaction |
| 15 | OEt | CH2 | Bu4NF, DMF | 23, 0.2 | 0.8:5.1:1 (7%) |
| 16 | OEt | CH2 | Bu4NF, THF | 23, 0.5 | no reaction |
| 17 | OEt | CH2 | Bu4NF, MeCN | 23, 0.2 | 0:3.4:1 |
| 18 | H | CH2 | Bu4NF, DMF | 23, 0.5 | 1.1:3.6:1 |
| 19 | H | H, OPMB | Bu4NF, DMA | 0, 1.0 | 2.9:2.2:1 |
| 20 | H | H, OPMB | Bu4NF, DMPU | 0, 1.0 | 3.2:1.9:1 40–50% |
Determined by NMR analysis of the crude mixture of products. Isolated yield of a is given in parentheses.
Scheme 13